{"filing":{"accession_number":"0001193125-26-252557","cik":"0002046386","ticker":"MDLN","company_name":"Medline Inc.","form":"8-K","filing_date":"2026-06-02","report_date":null,"primary_document":"d50280d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2046386/000119312526252557/d50280d8k.htm"},"events":[{"id":7439,"run_id":6538,"accession_number":"0001193125-26-252557","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"summary":"Medline Inc. entered into material definitive agreements on May 28, 2026, involving the issuance of $2.0 billion in senior secured notes (5.000% due 2031 and 5.250% due 2033) and refinancing of approximately $2.75 billion in term loan facilities, materially restructuring the company's debt obligations and capital structure.","company_name":"Medline Inc.","ticker":"MDLN","filing_date":"2026-06-02","form":"8-K","submitted_at":null,"items":[{"id":3540,"accession_number":"0001193125-26-252557","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"Medline Inc. entered into material definitive agreements on May 28, 2026, involving the issuance of $2.0 billion in senior secured notes (5.000% due 2031 and 5.250% due 2033) and refinancing of approximately $2.75 billion in term loan facilities. These transactions constitute a material capital structure event that restructures the company's debt obligations and materially affects its financial position. While technically a refinancing rather than a traditional M\u0026A transaction, the scale and complexity of the debt restructuring—including redemption of existing notes and refinancing of multiple facilities—constitutes a material financial event that would affect a reasonable investor's assessment of the registrant's capital structure and financial obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:15:00.797203+00:00","company_name":"","ticker":null,"filing_date":""},{"id":3541,"accession_number":"0001193125-26-252557","item_number":"2.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"Item 2.03 discloses creation of a direct financial obligation related to Notes and an Indenture Amendment, with details incorporated from Item 1.01. Without access to Item 1.01, the specific nature of the obligation cannot be determined—it could represent debt issuance, covenant modification, or another material financial event. The reference to an amendment and indenture suggests a debt-related transaction, but the exact event type (e.g., whether this is a new debt issuance, refinancing, or covenant breach trigger) remains ambiguous from this section alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:15:00.797203+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":7440,"run_id":6538,"accession_number":"0001193125-26-252557","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"Medline Inc. completed a large underwritten public offering of 72.5 million shares of Class A common stock at $37.00 per share by selling stockholders affiliated with Blackstone, Hellman \u0026 Friedman, and ADIA, generating approximately $2.7 billion in gross proceeds and materially affecting the company's equity structure and shareholder base.","company_name":"Medline Inc.","ticker":"MDLN","filing_date":"2026-06-02","form":"8-K","submitted_at":null,"items":[{"id":3542,"accession_number":"0001193125-26-252557","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"This disclosure reports completion of a large underwritten public offering of 72.5 million shares of Class A common stock at $37.00 per share by selling stockholders affiliated with Blackstone, Hellman \u0026 Friedman, and ADIA. While technically a secondary offering by existing shareholders rather than a primary issuance by the company, the scale (~$2.7 billion in gross proceeds) and the disclosure of conflicts of interest under FINRA Rule 5121 indicate material capital market activity affecting the registrant's equity structure and shareholder base. The filing emphasizes the offering's completion and underwriter conflicts, consistent with material equity event disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:15:00.797203+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3540,"accession_number":"0001193125-26-252557","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"Medline Inc. entered into material definitive agreements on May 28, 2026, involving the issuance of $2.0 billion in senior secured notes (5.000% due 2031 and 5.250% due 2033) and refinancing of approximately $2.75 billion in term loan facilities. These transactions constitute a material capital structure event that restructures the company's debt obligations and materially affects its financial position. While technically a refinancing rather than a traditional M\u0026A transaction, the scale and complexity of the debt restructuring—including redemption of existing notes and refinancing of multiple facilities—constitutes a material financial event that would affect a reasonable investor's assessment of the registrant's capital structure and financial obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:15:00.797203+00:00","company_name":"Medline Inc.","ticker":"MDLN","filing_date":"2026-06-02"},{"id":3541,"accession_number":"0001193125-26-252557","item_number":"2.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"Item 2.03 discloses creation of a direct financial obligation related to Notes and an Indenture Amendment, with details incorporated from Item 1.01. Without access to Item 1.01, the specific nature of the obligation cannot be determined—it could represent debt issuance, covenant modification, or another material financial event. The reference to an amendment and indenture suggests a debt-related transaction, but the exact event type (e.g., whether this is a new debt issuance, refinancing, or covenant breach trigger) remains ambiguous from this section alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:15:00.797203+00:00","company_name":"Medline Inc.","ticker":"MDLN","filing_date":"2026-06-02"},{"id":3542,"accession_number":"0001193125-26-252557","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"This disclosure reports completion of a large underwritten public offering of 72.5 million shares of Class A common stock at $37.00 per share by selling stockholders affiliated with Blackstone, Hellman \u0026 Friedman, and ADIA. While technically a secondary offering by existing shareholders rather than a primary issuance by the company, the scale (~$2.7 billion in gross proceeds) and the disclosure of conflicts of interest under FINRA Rule 5121 indicate material capital market activity affecting the registrant's equity structure and shareholder base. The filing emphasizes the offering's completion and underwriter conflicts, consistent with material equity event disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:15:00.797203+00:00","company_name":"Medline Inc.","ticker":"MDLN","filing_date":"2026-06-02"}]}